Who owns the GALT PHARMACEUTICALS trademark?

The GALT PHARMACEUTICALS trademark is owned by Galt Pharmaceuticals, LLC.

What class is the GALT PHARMACEUTICALS trademark registered in?

The GALT PHARMACEUTICALS trademark is registered in Class 035 (Advertising, business management & retail services).

What is the serial number for GALT PHARMACEUTICALS?

The USPTO serial number for GALT PHARMACEUTICALS is 87978500.

What is the registration number for GALT PHARMACEUTICALS?

GALT PHARMACEUTICALS is registered under USPTO registration number 5608954.

Sealvo

Home Search: GALT PHARMACEUTICALSGALT PHARMACEUTICALS #87978500

Back

Updated Sep 28, 2026·11 searches this week

View on USPTO TSDR Find similar marks

GAL

USPTO Trademark Record

REGISTERED

GALT PHARMACEUTICALS

SN 87978500·Reg 5608954·Filed Jun 14, 2017

Owner Galt Pharmaceuticals, LLC

Advertising; business management, organization and administration; office functions.

GALT PHARMACEUTICALS (Serial No. 87978500), Registration No. 5608954, is a registered US trademark filed on Jun 14, 2017 by Galt Pharmaceuticals, LLC. This trademark covers Class 035 (Advertising, business management & retail services).

Section 8/9 declaration window: November 13, 2028

Conflict Analysis

Full conflict analysis for GALT PHARMACEUTICALS (SN 87978500) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

GALT PHARMACEUTICALS (Reg. #5608954) is a registered US trademark that has been protecting its owner, Galt Pharmaceuticals, LLC, since 2017. The mark covers Class 035 (Advertising, business management & retail services). Goods and services include Advertising; business management, organization and administration; office functions..

FILED

Jun 14, 2017

SERIAL

87978500

REG#

5608954

REGISTERED

Nov 13, 2018

Filing Information

StatusREGISTERED

Filing DateJun 14, 2017

Serial Number87978500

Registration No.5608954

Registration DateNov 13, 2018

Status DateApr 14, 2025

Next RenewalNovember 13, 2028

Filing Basis & Declarations

Standard Characters ClaimedFiled as Use ApplicationUse Application CurrentlySection 8 Accepted

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 035Advertising, business management & retail services

US codes: 100, 101, 102

First use anywhere: May 08, 2017

First use in commerce: Jun 15, 2018

Advertising; business management, organization and administration; office functions.

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

39 events

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

Apr 14, 2025

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

REGISTERED - SEC. 8 (6-YR) ACCEPTED

Apr 14, 2025

REGISTERED - SEC. 8 (6-YR) ACCEPTED

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

Apr 14, 2025

NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED

TEAS SECTION 8 RECEIVED

Oct 03, 2024

TEAS SECTION 8 RECEIVED

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Nov 13, 2023

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

REGISTERED-SUPPLEMENTAL REGISTER

Nov 13, 2018

REGISTERED-SUPPLEMENTAL REGISTER

LAW OFFICE PUBLICATION REVIEW COMPLETED

Oct 09, 2018

LAW OFFICE PUBLICATION REVIEW COMPLETED

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

Oct 02, 2018

NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED

USE AMENDMENT ACCEPTED

Oct 01, 2018

USE AMENDMENT ACCEPTED

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

Oct 01, 2018

APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 27, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 27, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

AMENDMENT TO USE PROCESSING COMPLETE

Sep 27, 2018

AMENDMENT TO USE PROCESSING COMPLETE

DIVISIONAL PROCESSING COMPLETE

Sep 12, 2018

DIVISIONAL PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 11, 2018

CASE ASSIGNED TO INTENT TO USE PARALEGAL

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Sep 06, 2018

TEAS REQUEST FOR RECONSIDERATION RECEIVED

TEAS AMENDMENT OF USE RECEIVED

Sep 06, 2018

TEAS AMENDMENT OF USE RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Sep 06, 2018

TEAS REQUEST TO DIVIDE RECEIVED

DIVISIONAL REQUEST RECEIVED

Sep 06, 2018

DIVISIONAL REQUEST RECEIVED

USE AMENDMENT FILED

Sep 06, 2018

USE AMENDMENT FILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Aug 20, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Aug 20, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS REQUEST FOR RECONSIDERATION RECEIVED

Aug 14, 2018

TEAS REQUEST FOR RECONSIDERATION RECEIVED

FINAL REFUSAL WRITTEN

Mar 16, 2018

FINAL REFUSAL WRITTEN

FINAL REFUSAL E-MAILED

Mar 16, 2018

FINAL REFUSAL E-MAILED

NOTIFICATION OF FINAL REFUSAL EMAILED

Mar 16, 2018

NOTIFICATION OF FINAL REFUSAL EMAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 27, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 27, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Feb 27, 2018

TEAS/EMAIL CORRESPONDENCE ENTERED

ASSIGNED TO LIE

Feb 23, 2018

ASSIGNED TO LIE

CORRESPONDENCE RECEIVED IN LAW OFFICE

Feb 14, 2018

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS VOLUNTARY AMENDMENT RECEIVED

Feb 14, 2018

TEAS VOLUNTARY AMENDMENT RECEIVED

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Feb 13, 2018

TEAS RESPONSE TO OFFICE ACTION RECEIVED

NON-FINAL ACTION WRITTEN

Sep 15, 2017

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Sep 15, 2017

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Sep 15, 2017

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Sep 14, 2017

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 20, 2017

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jun 17, 2017

NEW APPLICATION ENTERED

Other Marks by Galt Pharmaceuticals, LLC

Additional USPTO filings from the same owner.

FEN

FENOPRON

98699136

Galt Pharmaceuticals, LLC

REGISTERED

PRE

PREV-RX

99029032

Galt Pharmaceuticals, LLC

REGISTERED

GAL

GALT PHARMACEUTICALS

87502346

Galt Pharmaceuticals, LLC

REGISTERED

TOL

TOLECTIN

88034829

Galt Pharmaceuticals, LLC

REGISTERED

Other Marks in Class 035 — Advertising, business management & retail services

Recently filed and registered marks in the same international class.

GAL

GALT PHARMACEUTICALS

87502346

Galt Pharmaceuticals, LLC

REGISTERED

GAL

GALT.

79365771

ITT Italia S.r.l.

REGISTERED

GAL

GALT INTERNATIONAL

88841061

Galt International Company, Inc.

REGISTERED

BRA

BRADFORD & GALT

75171156

Bradford and Galt, Incorporated

REGISTERED

Other Marks by Chelsea G. Swanson

Additional USPTO filings handled by the same attorney of record.

FEN

FENOPRON

98699136

REGISTERED

PRE

PREV-RX

99029032

REGISTERED

GAL

GALT PHARMACEUTICALS

87502346

REGISTERED

TOL

TOLECTIN

88034829

REGISTERED

GALT PHARMACEUTICALS

Run a conflict check

Other Marks by Galt Pharmaceuticals, LLC

Other Marks in Class 035 — Advertising, business management & retail services

Other Marks by Chelsea G. Swanson

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company